Your browser doesn't support javascript.
loading
The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia.
Østergaard, Anna; Enshaei, Amir; Pieters, Rob; Vora, Ajay; Horstmann, Martin A; Escherich, Gabriele; Johansson, Bertil; Heyman, Mats; Schmiegelow, Kjeld; Hoogerbrugge, Peter M; den Boer, Monique L; Kuiper, Roland P; Moorman, Anthony V; Boer, Judith M; van Leeuwen, Frank N.
Afiliação
  • Østergaard A; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Enshaei A; Oncode Institute, Utrecht, Netherlands.
  • Pieters R; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Vora A; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Horstmann MA; Department of Haematology, Great Ormond Street Hospital, London, United Kingdom.
  • Escherich G; Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Johansson B; University Medical Center Hamburg, Research Institute Children's Cancer Center, Hamburg, Germany.
  • Heyman M; Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schmiegelow K; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden.
  • Hoogerbrugge PM; Department of Clinical Genetics, Pathology, and Molecular Diagnostics, Office for Medical Services, Region Skåne, Lund, Sweden.
  • den Boer ML; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Kuiper RP; Department of Paediatric Oncology, Karolinska University Hospital, Stockholm, Sweden.
  • Moorman AV; Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Denmark.
  • Boer JM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • van Leeuwen FN; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Hemasphere ; 7(5): e875, 2023 May.
Article em En | MEDLINE | ID: mdl-37153875

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Hemasphere Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Hemasphere Ano de publicação: 2023 Tipo de documento: Article